Robert Pierce

2022 - Sensei Biotherapeutics

In 2022, Robert Pierce earned a total compensation of $1.2M as Former Chief R&D Officer at Sensei Biotherapeutics, a 47% decrease compared to previous year.

Compensation breakdown

Option Awards$298,251
Salary$421,154
Stock Awards$90,300
Other$377,572
Total$1,187,277

Pierce received $421.2K in salary, accounting for 35% of the total pay in 2022.

Pierce also received $298.3K in option awards, $90.3K in stock awards and $377.6K in other compensation.

Rankings

In 2022, Robert Pierce's compensation ranked 2,701st out of 5,736 executives tracked by ExecPay. In other words, Pierce earned more than 52.9% of executives.

ClassificationRankingPercentile
All
2,701
out of 5,736
53rd
Division
Manufacturing
1,501
out of 3,125
52nd
Major group
Chemicals And Allied Products
692
out of 1,416
51st
Industry group
Drugs
645
out of 1,317
51st
Industry
Pharmaceutical Preparations
465
out of 963
52nd
Source: SEC filing on June 15, 2023.

Pierce's colleagues

We found three more compensation records of executives who worked with Robert Pierce at Sensei Biotherapeutics in 2022.

2022

John Celebi

Sensei Biotherapeutics

Chief Executive Officer

2022

Erin Colgan

Sensei Biotherapeutics

Chief Financial Officer

2022

Edward der Horst

Sensei Biotherapeutics

Chief Scientific Officer

News

You may also like